close
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Agilent Technologies (NY:A)

136.62 -3.49 (-2.49%)
Official Closing Price Updated: 7:00 PM EDT, Oct 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Agilent Technologies

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
This W.W. Grainger Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Wednesday
 
Via Benzinga
Here's How Much You Would Have Made Owning Agilent Technologies Stock In The Last 10 Years
 
Via Benzinga
3 Healthcare Stocks We Think Twice About
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the... 
Via StockStory
Topics Stocks
Assessing Agilent Technologies: Insights From 7 Financial Analysts
 
Via Benzinga
Thermo Fisher Scientific Soars on Strategic Wins, Market Optimism
Thermo Fisher Scientific Inc. (NYSE: TMO) experienced a robust surge in its stock value today, October 1, 2025, climbing an impressive 9.79% as market optimism swelled around a series of recent... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
Trump-Pfizer Deal Pushes Health Care Stocks To Best Rally In 5 Years
Health care stocks rallied after Trump struck a drug pricing deal with Pfizer, offering major discounts and pausing pharma tariffs. 
Via Benzinga
Topics Government
U.S. Drug Pricing Reforms Send Ripples Across Global Healthcare Sector
The global healthcare sector is currently navigating a period of profound transformation, driven by aggressive regulatory changes emanating from the United States. As of late September 2025, a series... 
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape
September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
Agilent (A) Soars as White House-Pfizer Drug-Pricing Agreement Signals New Era for Pharma
Washington D.C. – September 30, 2025 – Shares of Agilent Technologies (NYSE: A) experienced a significant upward movement today, closing strong amidst breaking news of a landmark drug-pricing agreement... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
Pharmaceutical Pricing Shake-Up Casts Long Shadow on Biotech Suppliers, Bruker Navigates Headwinds Amidst Market Volatility
As of September 30, 2025, the financial markets are grappling with the implications of a landmark drug-pricing agreement between the White House and pharmaceutical giant Pfizer (NYSE: PFE), a move... 
Via MarketMinute
Topics Economy Government Supply Chain
Where Agilent Technologies Stands With Analysts
 
Via Benzinga
Earnings Outlook For Agilent Technologies
 
Via Benzinga
Bruker, Agilent, Revvity, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. 
Via StockStory
Topics Government
Discover which S&P500 stocks are making waves on Tuesday.
Curious about the top performers within the S&P500 index in the middle of the day on Tuesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
1 Cash-Producing Stock with Impressive Fundamentals and 2 We Question
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
Looking Into Agilent Technologies's Recent Short Interest
 
Via Benzinga
Agilent Technologies Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)
 
Via Benzinga
1 Magnificent S&P 500 Dividend Stock I'm Buying Right Now
Nasdaq looks primed to continue its run of stomping the market. 
Via The Motley Fool
Topics Artificial Intelligence Fraud Stocks
Research Tools & Consumables Stocks Q2 Teardown: Agilent (NYSE:A) Vs The Rest
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at research tools & consumables stocks,... 
Via StockStory
Topics Economy
Exploring the top movers within the S&P500 index during today's session.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday. 
Via Chartmill
Agilent (A) Stock Trades Up, Here Is Why
Shares of life sciences tools company Agilent Technologies (NYSE:A) jumped 3.7% in the morning session after the company reported better-than-expected revenue in its second-quarter 2025 results and... 
Via StockStory
Topics Artificial Intelligence Economy Stocks
Discover which S&P500 stocks are making waves on Thursday.
Stay informed about the performance of the S&P500 index in the middle of the day on Thursday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
A Q3 Deep Dive: Pharma and Materials Demand Drive Growth, Margin Pressures Persist
Life sciences tools company Agilent Technologies (NYSE:A) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 10.1% year on year to $1.74 billion. On top of that, next quarter’s revenue... 
Via StockStory
Agilent Reports 10% Revenue Jump in Q3
Via The Motley Fool
Topics World Trade
Agilent Raises Outlook on Q3 Growth
Via The Motley Fool
Topics Earnings World Trade
Agilent Technologies Inc (NYSE:A) Q3 2025 Earnings: Revenue Beat Offsets EPS Miss
Agilent (A) beat Q3 FY25 revenue estimates with $1.74B but slightly missed on EPS. The company posted strong growth across all segments and provided optimistic full-year guidance. 
Via Chartmill
Agilent’s (NYSE:A) Q2 Sales Top Estimates, Full-Year Sales Guidance is Optimistic
Life sciences tools company Agilent Technologies (NYSE:A) announced better-than-expected revenue in Q2 CY2025, with sales up 10.1% year on year to $1.74 billion. On top of that, next quarter’s revenue... 
Via StockStory
S&P 500 Tests Records Ahead Nvidia Results, MongoDB Rockets: What's Moving Markets Wednesday?
Wall Street traded cautiously on Wednesday, with major indices little changed at midday as investors awaited NVIDIA Corp.‘s (NASDAQ:NVDA) second-quarter earnings after the bell. 
Via Benzinga
Topics Stocks
Earnings Scheduled For August 27, 2025
 
Via Benzinga
Analysts Love These 3 Companies Reporting Earnings This Week
Three standout firms reporting earnings in the last week of August have analyst support and investor attention—but how will they perform? 
Via MarketBeat
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Starting at $3.75/week.

Subscribe Today